Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty

Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Jun 22, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new navigation system designed to help doctors perform total knee replacement surgery, specifically for patients with gonarthrosis, which is a type of knee arthritis. The goal is to see if this new system can improve the accuracy and outcomes of the surgery.

To participate, you need to be an adult aged 65-74 who has been diagnosed with knee arthritis and has been advised by a doctor to undergo knee replacement surgery. You should not have had previous knee surgeries or certain health conditions that could complicate the surgery. If you join the trial, you will be carefully monitored during and after the surgery to assess how well the new navigation system works. It's important to note that this trial is currently looking for participants, so if you meet the criteria and are interested, you could play a key role in helping to improve knee surgery techniques.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult man or woman who has signed the informed consent for participation in the study,
• • Patient with primary uni or bilateral gonarthrosis
• • For whom an indication for total knee arthroplasty has been given
• Exclusion Criteria:
• • History of fracture, arthroplasty or osteotomy of the knee
• • Severe preoperative laxity warranting a constrained prosthesis
• • Inflammatory rheumatic disease or any other progressive concomitant condition that may impact on the patient's functional prognosis
• • Traumatic articular or extra-articular deformities of the lower limb
• • Neurological disease, after-effects of a stroke
• • Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol
• • Patient not affiliated to the French social security system
• • Patient under legal protection, guardianship or curatorship
• • Patient already included in another therapeutic study protocol or having participated in another trial in the previous three months